Genome Sequencing and Analysis of the First Spontaneous Nanosilver 4 Resistant Bacterium Proteus Mirabilis Strain SCDR1
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
POTENTIAL MICROBIAL DETOXIFIERS of Mehg in BARCELONA CITY CONTINENTAL SHELF
POTENTIAL MICROBIAL DETOXIFIERS OF MeHg IN BARCELONA CITY CONTINENTAL SHELF TREBALL REALITZAT PER Marina Pérez García PER OBTENIR EL TÍTOL DE Màster en Microbiologia Avançada 2017-2018 Treball de Final de Màster realitzat sota la supervisió la Dra Silvia González-Acinas i la Dra Andrea García Bravo a l’Institut de Ciències del Mar (ICM-CSIC) Barcelona, 03 de Setembre de 2018 POTENTIAL MICROBIAL DETOXIFIERS OF MeHg IN BARCELONA CITY CONTINENTAL SHELF TREBALL REALITZAT PER Marina Pérez García PER OBTENIR EL TÍTOL DE Màster en Microbiologia Avançada 2017-2018 Treball de Final de Màster realitzat sota la supervisió la Dra Silvia González-Acinas i la Dra Andrea García Bravo a l’Institut de Ciències del Mar (ICM-CSIC) Barcelona, 03 de Setembre de 2018 Silvia González-Acinas Marina Pérez García Andrea García Bravo Abstract Mercury specially in the form of Methylmercury (MeHg) is a big concern because affects human and wildlife health and accumulates and biomagnified in the aquatics systems through the food chain. Some Bacteria and Archaea have evolved resistance mechanisms to mercury compounds, this resistance is encoded in the mer operon. So, the microorganisms that have merA and merB genes can completely transform the neurotoxic form of MeHg in the volatile form of mercury. Despite the persistence of mercury there is no information about the mercury detoxification processes in Barcelona continental shelf. Therefore, the aim of this study is to detect the presence of merA and merB in past (1987 and 2008) and present (from two months April and May 2018) sediment samples from the Barcelona continental shelf. -
Alterations of Genetic Variants and Transcriptomic Features of Response to Tamoxifen in the Breast Cancer Cell Line
Alterations of Genetic Variants and Transcriptomic Features of Response to Tamoxifen in the Breast Cancer Cell Line Mahnaz Nezamivand-Chegini Shiraz University Hamed Kharrati-Koopaee Shiraz University https://orcid.org/0000-0003-2345-6919 seyed taghi Heydari ( [email protected] ) Shiraz University of Medical Sciences https://orcid.org/0000-0001-7711-1137 Hasan Giahi Shiraz University Ali Dehshahri Shiraz University of Medical Sciences Mehdi Dianatpour Shiraz University of Medical Sciences Kamran Bagheri Lankarani Shiraz University of Medical Sciences Research Keywords: Tamoxifen, breast cancer, genetic variants, RNA-seq. Posted Date: August 17th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-783422/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/33 Abstract Background Breast cancer is one of the most important causes of mortality in the world, and Tamoxifen therapy is known as a medication strategy for estrogen receptor-positive breast cancer. In current study, two hypotheses of Tamoxifen consumption in breast cancer cell line (MCF7) were investigated. First, the effect of Tamoxifen on genes expression prole at transcriptome level was evaluated between the control and treated samples. Second, due to the fact that Tamoxifen is known as a mutagenic factor, there may be an association between the alterations of genetic variants and Tamoxifen treatment, which can impact on the drug response. Methods In current study, the whole-transcriptome (RNA-seq) dataset of four investigations (19 samples) were derived from European Bioinformatics Institute (EBI). At transcriptome level, the effect of Tamoxifen was investigated on gene expression prole between control and treatment samples. -
Genome and Pangenome Analysis of Lactobacillus Hilgardii FLUB—A New Strain Isolated from Mead
International Journal of Molecular Sciences Article Genome and Pangenome Analysis of Lactobacillus hilgardii FLUB—A New Strain Isolated from Mead Klaudia Gustaw 1,* , Piotr Koper 2,* , Magdalena Polak-Berecka 1 , Kamila Rachwał 1, Katarzyna Skrzypczak 3 and Adam Wa´sko 1 1 Department of Biotechnology, Microbiology and Human Nutrition, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna 8, 20-704 Lublin, Poland; [email protected] (M.P.-B.); [email protected] (K.R.); [email protected] (A.W.) 2 Department of Genetics and Microbiology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Akademicka 19, 20-033 Lublin, Poland 3 Department of Fruits, Vegetables and Mushrooms Technology, Faculty of Food Science and Biotechnology, University of Life Sciences in Lublin, Skromna 8, 20-704 Lublin, Poland; [email protected] * Correspondence: [email protected] (K.G.); [email protected] (P.K.) Abstract: The production of mead holds great value for the Polish liquor industry, which is why the bacterium that spoils mead has become an object of concern and scientific interest. This article describes, for the first time, Lactobacillus hilgardii FLUB newly isolated from mead, as a mead spoilage bacteria. Whole genome sequencing of L. hilgardii FLUB revealed a 3 Mbp chromosome and five plasmids, which is the largest reported genome of this species. An extensive phylogenetic analysis and digital DNA-DNA hybridization confirmed the membership of the strain in the L. hilgardii species. The genome of L. hilgardii FLUB encodes 3043 genes, 2871 of which are protein coding sequences, Citation: Gustaw, K.; Koper, P.; 79 code for RNA, and 93 are pseudogenes. -
Molecular and Immunological Sd0100025 Characterization of Mycobacteria Associated with Bovine Farcy
MOLECULAR AND IMMUNOLOGICAL SD0100025 CHARACTERIZATION OF MYCOBACTERIA ASSOCIATED WITH BOVINE FARCY. Thesis submitted in accordance with requirements of the University of Khartoum for the Degree of Doctor of Philosophy (Ph.D). By Victor Loku Kwajok B.V.Med. 1978, University of Cairo/Egypt. M.V.Sc.1992, University of Khartoum/Sudan. Supervisor: Dr. Maowia M. Mukhtar. Institute of Endemic Diseases, University of Khartoum. Department of Preventive Medicine and Veterinary Public Health. Faculty of Veterinary Science, University of Khartoum. 2000. 32/27 SOME PAGES ARE MISSING IN THE ORIGINAL DOCUMENT LIST OF CONTENTS DEDICATION. * ii v ACKNOWLEDGEMENTS vi ABBREVIATIONS viii ABSTRACT. xi CHAPTER ONE. REVIEW OF LITERATURE. 1. General Introduction. 1. 1.1. Molecular Systematics of genus Mycobacterium. 2. 1.2. Molecular taxonomy of M. farcinogenese and M. senegalense 11. 1.3. Immunology of bovine farcy agents. 36. CHAPTER TWO. MATERIALS AND METHODOLOGY 41. Isolation, identification and characterization of M. farcinogenes. 2.1 Phenotypic characterization. 41. 2.1.1. Morphological and biochemical tests. 2.1.2. Degradation tests. 2.1.3. Rapid fluorogenic enzyme tests. 2.1.4. Nutritional tests. 2.1.5. Physiological tests. 2.2. Molecular characterization. 52. 2.2.1. DNA extraction and purification 2.2.2. PCR amplification and application. 2.2.3. DNA sequencing of 16SrDNA. 2.2.4. PCR-based restriction fragment length polymorphism. 2.3 Imrmmological analyses of bovine farcy agents. 71. 2.3.1 .EL1SA technique for sera diagnosis. 2.3.2 Animal pathogenicity Tests. 2.3.3 Protein antigen profiles determination using. CHAPTER THREE: RESULTS. 78. CHAPTER. FOUR: DISCUSSION. 124. REFERENCES. 133. -
Bioinformatics Resource Centers Systems Biology (Brcs) Centers
Fondation Merieux – J Craig Venter Institute Bioinformatics Workshop December 5 – 8, 2017 Module 3: Genomic Data & Sequence Annotations in Public Databases NIH/NIAID Genomics and Bioinformatics Program SlideSource:A.S.Fauci SlideSource:A.S.Fauci Conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. NIAIDGenomicsProgram Proteomics Systems Sequencing Functional Structural Biology Genomics Genomics Genomic Clinical Functional Systems Sequencing Proteomics Structural Genomic Biology Centers Centers Genomics Research Centers Centers Centers Bioinformatics BioinformaticsResource Centers GenomicResearchResources Genomic/OmicsDataSets,Databases,BioinformaticsTools,Biomarkers,3DStructures,ProteinClones,PredictiveModels Toaddresskeyquestionsin microbiologyandinfectious disease NIAID Genome Sequencing Center Influenza Genome Sequencing Project at JCVI • 2004: 80 influenza genomes in GenBank • 3OCT2017: ~20,000 influenza genomes sequenced at JCVI • 75% complete influenza genomes in GenBank by JCVI Slide source: Maria Giovanni * Genome Sequencing Centers Bioinformatics Resource Centers Systems Biology (BRCs) Centers Structure Genomics Centers Clinical Proteomics Centers Courtesy of Alison Yao, DMID *Bioinformatics Resource Centers (BRCs) Goal: Provide integrated bioinformatics resources in support of basic and applied infectious diseases research • Data and metadata management and integration solutions • Computational analysis and visualization tools • Work -
(Roll No. 107Bt006) Santosh Kumar Nayak (Roll No
IN SILICO ANNOTATION OF UN-CHARACTERIZED PROTEINS OF MYCOBACTERIUM TUBERCULOSIS A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENT FOR THE DEGREE OF Bachelor of Technology in Biotechnology Engineering By KIRAN SOY MURUM (ROLL NO. 107BT006) SANTOSH KUMAR NAYAK (ROLL NO. 107BT009) Department of Biotechnology & Medical Engineering National Institute of Technology Rourkela-769008 1 IN SILICO ANNOTATION OF UN-CHARACTERIZED PROTEINS OF MYCOBACTERIUM TUBERCULOSIS A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENT FOR THE DEGREE OF Bachelor of Technology In Biotechnology Engineering By KIRAN SOY MURUM (ROLL NO. 107BT006) SANTOSH KUMAR NAYAK (ROLL NO. 107BT009) Under the Guidance of Prof. G.R.Sathpathy Department of Biotechnology & Medical Engineering National Institute of Technology Rourkela-769008 2 National Institute of Technology Rourkela CERTIFICATE This is to certify that the thesis entitled, “Insilico Annotation of Un-characterized proteins of Mycobacterium Tuberculosis “submitted by Santosh Kumar Nayak and Kiran Soy Murum in partial fulfillment of the requirement for the award of bachelor of technology degree in Biotechnology Engineering at National Institute of Technology, Rourkela (Deemed University) is an authentic work carried out by them under my supervision and guidance. To the best of my knowledge the matter embodied in the thesis has not been submitted to any other University/Institute for award of any Degree/Diploma. Date: Prof.G.R. Satpathy Dept. Of Biotechnology & Medical Engg. National Institute of Technology Rourkela-769008 3 Acknowledgement We express our sincere gratitude to Dr. G.R.Satpathy, Professor of the Department of Biotechnology Engineering, National Institute of Technology, Rourkela, for giving us this great opportunity to work under his guidance throughout the course of this work. -
Antibiotic Sensitivity of Bacterial Pathogens Isolated from Bovine Mastitis Milk
Content of Research Report A. Project title: Antibiotic Sensitivity of Bacterial Pathogens Isolated From Bovine Mastitis Milk B. Abstract: Antibiotic sensitivity of bacteria isolated from bovine milk samples was investigated. The 18 antibiotics that were evaluated (e.g., penicillin, novobiocin, gentamicin) are commonly used to treat various diseases in cattle, including mastitis, an inflammation of the udder of dairy cows. A common concern in using antibiotics is the increase in drug resistance with time. This project studies if antibiotic resistance is a threat to consumers of raw milk products and if these antibiotics are still effective against mastitis pathogens. The study included isolating and culturing bacteria from quarter milk samples (n=205) collected from mastitic dairy cows from farms in Chino and Ontario, CA. The isolated bacteria were tested for sensitivity to antibiotics using the Kirby Bauer disk diffusion method. The prevalence (%) of resistance to the individual antibiotics was reported. Resistance to penicillin was 45% which may support previous data on penicillin-resistant bacteria, especially Staphylococcus and Streptococcus. Resistance rates (%) for oxytetracycline (26.8%) and tetracycline (22.9%) were low compared to previous studies but a trend was seen in our results that may support concerns of emerging resistance to tetracyclines in both gram- positive and gram-negative bacteria. Similarly, 31.9% of bacterial isolates showed resistance to erythromycin which is at least 30% less than in reported literature concerning emerging resistance to macrolides. More numbers (%) that should be noted are cefazolin (26.3%), ampicillin (29.7%), novobiocin (33.0%), polymyxin B (31.5%), and resistance ranging from 9 18% for the other antibiotics. -
Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing -
Metabolic and Genetic Basis for Auxotrophies in Gram-Negative Species
Metabolic and genetic basis for auxotrophies in Gram-negative species Yara Seifa,1 , Kumari Sonal Choudharya,1 , Ying Hefnera, Amitesh Ananda , Laurence Yanga,b , and Bernhard O. Palssona,c,2 aSystems Biology Research Group, Department of Bioengineering, University of California San Diego, CA 92122; bDepartment of Chemical Engineering, Queen’s University, Kingston, ON K7L 3N6, Canada; and cNovo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 Lyngby, Denmark Edited by Ralph R. Isberg, Tufts University School of Medicine, Boston, MA, and approved February 5, 2020 (received for review June 18, 2019) Auxotrophies constrain the interactions of bacteria with their exist in most free-living microorganisms, indicating that they rely environment, but are often difficult to identify. Here, we develop on cross-feeding (25). However, it has been demonstrated that an algorithm (AuxoFind) using genome-scale metabolic recon- amino acid auxotrophies are predicted incorrectly as a result struction to predict auxotrophies and apply it to a series of the insufficient number of known gene paralogs (26). Addi- of available genome sequences of over 1,300 Gram-negative tionally, these methods rely on the identification of pathway strains. We identify 54 auxotrophs, along with the corre- completeness, with a 50% cutoff used to determine auxotrophy sponding metabolic and genetic basis, using a pangenome (25). A mechanistic approach is expected to be more appropriate approach, and highlight auxotrophies conferring a fitness advan- and can be achieved using genome-scale models of metabolism tage in vivo. We show that the metabolic basis of auxotro- (GEMs). For example, requirements can arise by means of a sin- phy is species-dependent and varies with 1) pathway structure, gle deleterious mutation in a conditionally essential gene (CEG), 2) enzyme promiscuity, and 3) network redundancy. -
Unexpected Drug Residuals in Human Milk in Ankara, Capital of Turkey Ayşe Meltem Ergen1 and Sıddıka Songül Yalçın2*
Ergen and Yalçın BMC Pregnancy and Childbirth (2019) 19:348 https://doi.org/10.1186/s12884-019-2506-1 RESEARCH ARTICLE Open Access Unexpected drug residuals in human milk in Ankara, capital of Turkey Ayşe Meltem Ergen1 and Sıddıka Songül Yalçın2* Abstract Background: Breast milk is a natural and unique nutrient for optimum growth and development of the newborn. The aim of this study was to investigate the presence of unpredictable drug residues in mothers’ milk and the relationship between drug residues and maternal-infant characteristics. Methods: In a descriptive study, breastfed infants under 3 months of age and their mothers who applied for child health monitoring were enrolled for the study. Information forms were completed for maternal-infant characteristics, breastfeeding problems, crying and sleep characteristics of infants. Maternal and infant anthropometric measurements and maternal milk sample were taken. Edinburgh Postpartum Depression Scale was applied to mothers. RANDOX Infiniplex kit for milk was used for residual analysis. Results: Overall, 90 volunteer mothers and their breastfed infants were taken into the study and the mean age of the mothers and their infants was 31.5 ± 4.2 years and 57.8 ± 18.1 days, respectively. Anti-inflammatory drug residues in breast milk were detected in 30.0% of mothers and all had tolfenamic acid. Overall, 94.4% had quinolone, 93.3% beta-lactam, 31.1% aminoglycoside and 13.3% polymycin residues. Drugs used during pregnancy or lactation period were not affected by the presence of residues. Edinburgh postpartum depression scores of mothers and crying and sleeping problems of infants were similar in cases with and without drug residues in breast milk. -
Insights Into the Phylogeny and Evolution of Cold Shock Proteins: from Enteropathogenic Yersinia and Escherichia Coli to Eubacteria
International Journal of Molecular Sciences Article Insights into the Phylogeny and Evolution of Cold Shock Proteins: From Enteropathogenic Yersinia and Escherichia coli to Eubacteria Tao Yu 1,2,* , Riikka Keto-Timonen 2 , Xiaojie Jiang 2, Jussa-Pekka Virtanen 2 and Hannu Korkeala 2 1 Department of Life Science and Technology, Xinxiang University, Xinxiang 453003, China 2 Department of Food Hygiene and Environmental Health, University of Helsinki, P.O. Box 66, FI-00014 Helsinki, Finland * Correspondence: yu.tao@helsinki.fi Received: 21 July 2019; Accepted: 16 August 2019; Published: 20 August 2019 Abstract: Psychrotrophic foodborne pathogens, such as enteropathogenic Yersinia, which are able to survive and multiply at low temperatures, require cold shock proteins (Csps). The Csp superfamily consists of a diverse group of homologous proteins, which have been found throughout the eubacteria. They are related to cold shock tolerance and other cellular processes. Csps are mainly named following the convention of those in Escherichia coli. However, the nomenclature of certain Csps reflects neither their sequences nor functions, which can be confusing. Here, we performed phylogenetic analyses on Csp sequences in psychrotrophic enteropathogenic Yersinia and E. coli. We found that representative Csps in enteropathogenic Yersinia and E. coli can be clustered into six phylogenetic groups. When we extended the analysis to cover Enterobacteriales, the same major groups formed. Moreover, we investigated the evolutionary and structural relationships and the origin time of Csp superfamily members in eubacteria using nucleotide-level comparisons. Csps in eubacteria were classified into five clades and 12 subclades. The most recent common ancestor of Csp genes was estimated to have existed 3585 million years ago, indicating that Csps have been important since the beginning of evolution and have enabled bacterial growth in unfavorable conditions. -
Fostering Research Into Antimicrobial Resistance in India
ANTIMICROBIAL RESISTANCE IN SOUTH EAST ASIA Fostering research into antimicrobial resistance BMJ: first published as 10.1136/bmj.j3535 on 6 September 2017. Downloaded from in India Bhabatosh Das and colleagues discuss research and development of new antimicrobials and rapid diagnostics, which are crucial for tackling antimicrobial resistance in India ndia is among the world’s largest Box 1: Examples of the impact of antimicrobial resistance research and interventions consumers of antibiotics.1 The efficacy globally of several antibiotics is threatened by the emergence of resistant microbial • In 2011, the Chinese Ministry of Health implemented a campaign for rational use of pathogens. Multiple factors, such antibiotics in healthcare, accompanied by supervision audits and inspections. Over a year, Ias a high burden of disease, poor public superfluous prescription of antimicrobials was reduced by 10-12% for patients in hospital 45 health infrastructure, rising incomes, and and for outpatients, as were drug sales for antimicrobials. unregulated sales of cheap antibiotics, • The Swedish Strategic Programme against Antibiotic Resistance (STRAMA) led to a decrease have amplified the crisis of antimicrobial in antibiotic use for outpatients from 15.7 to 12.6 daily doses per 1000 inhabitants and from resistance (AMR) in India.2 536 to 410 prescriptions per 1000 inhabitants per year from 1995 to 2004.6 The decrease The Global Action Plan on AMR was most evident for macrolides (65%) emphasises the need to increase • The effect of WHO essential medicines policies was studied in 55 countries. These policies knowledge through surveillance and were linked to reductions in antibiotic use of ≥20% in upper respiratory tract infections.